Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
7.31
+1.41 (23.90%)
Jan 2, 2026, 6:10 PM HKT
Charmacy Pharmaceutical Revenue
Charmacy Pharmaceutical had revenue of 2.16B CNY in the half year ending June 30, 2025, a decrease of -5.02%. This brings the company's revenue in the last twelve months to 4.24B, down -5.32% year-over-year. In the year 2024, Charmacy Pharmaceutical had annual revenue of 4.44B with 0.72% growth.
Revenue (ttm)
4.24B CNY
Revenue Growth
-5.32%
P/S Ratio
0.17
Revenue / Employee
5.01M CNY
Employees
847
Market Cap
786.24M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.44B | 31.83M | 0.72% |
| Dec 31, 2023 | 4.40B | 228.35M | 5.47% |
| Dec 31, 2022 | 4.18B | 381.66M | 10.06% |
| Dec 31, 2021 | 3.79B | -198.09M | -4.96% |
| Dec 31, 2020 | 3.99B | 498.93M | 14.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |